Skip to main content
Erschienen in: Drug Safety 3/2001

01.03.2001 | Original Reasearch Article

Temporal Patterns of NSAID Spontaneous Adverse Event Reports

The Weber Effect Revisited

verfasst von: Eric J. Wallenstein, Dr Daniel Fife

Erschienen in: Drug Safety | Ausgabe 3/2001

Einloggen, um Zugang zu erhalten

Abstract

Objectives: Determine whether recent US adverse event reports for several nonsteroidal anti-inflammatory drugs (NSAIDs) conform to the temporal pattern observed by Dr JCP Weber in the UK in the early 1980s, i.e. a rising count in the first few years after launch presumably reflecting increased exposure, followed by a decline, presumably reflecting decreased enthusiasm for reporting as adverse events become well known.
Study Setting: US adverse event report data available from the US Food and Drug Administration, reformatted by a commercial vendor.
Methods: For the 5 NSAIDs launched in the US between 1987 and 1993 that had data suitable for this study, we tabulated by year from launch the number of reports and the reporting rate (number of reports per 1000 prescriptions).
Results: The number of reports for 3 of the 5 NSAIDs showed a temporal pattern approximating that described by Weber. The number of reports for the other 2 NSAIDs showed temporal patterns markedly different from that described by Weber. For 4 of the 5 NSAIDs, reporting rates did not decline consistently with time from launch.
Discussion: The temporal patterns of adverse event reports are more complex than those described in Weber’s classic report. The number of reports does not reliably rise and then fall after launch and the reporting rate does not reliably decrease with time from launch.
Literatur
1.
Zurück zum Zitat Weber, JCP. Epidemiology of adverse reactions to nonsteroidal antiinflammatory drugs. Adv Inflam Res 1984; 6: 1–7 Weber, JCP. Epidemiology of adverse reactions to nonsteroidal antiinflammatory drugs. Adv Inflam Res 1984; 6: 1–7
2.
Zurück zum Zitat International Medical Statistics Health Inc. National prescription audit plus therapeutic category report. International Medical Statistics Health Inc.,Vols Jul-Dec 1987–1999 International Medical Statistics Health Inc. National prescription audit plus therapeutic category report. International Medical Statistics Health Inc.,Vols Jul-Dec 1987–1999
5.
Zurück zum Zitat Sherman SW. Letter regarding NDA 19-583 Relafen (nabumetone) Tablets MACMIS ID #4877. FDA Department of Health and Human Services, 1997 Jan 23 Sherman SW. Letter regarding NDA 19-583 Relafen (nabumetone) Tablets MACMIS ID #4877. FDA Department of Health and Human Services, 1997 Jan 23
6.
Zurück zum Zitat Cramer RL, Aboko-Cole VC, Gualtieri RJ. Agranulocytosis associated with etodolac. Ann Pharmacother 1994; 28(4): 458–60PubMed Cramer RL, Aboko-Cole VC, Gualtieri RJ. Agranulocytosis associated with etodolac. Ann Pharmacother 1994; 28(4): 458–60PubMed
7.
Zurück zum Zitat Pal B, Hutchinson A, Bhattacharya A, Ralston A. Cardiac arrest due to severe hyperkalaemia in patient taking nabumetone and low salt diet. BMJ 1995; 311: 1486–7PubMedCrossRef Pal B, Hutchinson A, Bhattacharya A, Ralston A. Cardiac arrest due to severe hyperkalaemia in patient taking nabumetone and low salt diet. BMJ 1995; 311: 1486–7PubMedCrossRef
Metadaten
Titel
Temporal Patterns of NSAID Spontaneous Adverse Event Reports
The Weber Effect Revisited
verfasst von
Eric J. Wallenstein
Dr Daniel Fife
Publikationsdatum
01.03.2001
Verlag
Springer International Publishing
Erschienen in
Drug Safety / Ausgabe 3/2001
Print ISSN: 0114-5916
Elektronische ISSN: 1179-1942
DOI
https://doi.org/10.2165/00002018-200124030-00006

Weitere Artikel der Ausgabe 3/2001

Drug Safety 3/2001 Zur Ausgabe